268 related articles for article (PubMed ID: 17103289)
1. Gender and gallstone disease.
Novacek G
Wien Med Wochenschr; 2006 Oct; 156(19-20):527-33. PubMed ID: 17103289
[TBL] [Abstract][Full Text] [Related]
2. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.
Wang HH; Liu M; Clegg DJ; Portincasa P; Wang DQ
Biochim Biophys Acta; 2009 Nov; 1791(11):1037-47. PubMed ID: 19589396
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives in gall stone diseases.
Khan MK; Jalil MA; Khan MS
Mymensingh Med J; 2007 Jul; 16(2 Suppl):S40-45. PubMed ID: 17917630
[TBL] [Abstract][Full Text] [Related]
4. Gall-stones and oral contraceptives.
Howat JM; Jones CB; Schofield PF
J Int Med Res; 1975; 3(2):59-62. PubMed ID: 1140507
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic estrogen application on bile and gallstone composition in women with cholelithiasis.
Sieron D; Czerny B; Sieron-Stoltny K; Karasiewicz M; Bogacz A; Seremak-Mrozikiewicz A; Kotrych D; Boron D; Mrozikiewicz P
Minerva Endocrinol; 2016 Mar; 41(1):19-27. PubMed ID: 25413941
[TBL] [Abstract][Full Text] [Related]
6. Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians.
Gälman C; Miquel JF; Pérez RM; Einarsson C; Ståhle L; Marshall G; Nervi F; Rudling M
Gastroenterology; 2004 Mar; 126(3):741-8. PubMed ID: 14988828
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with gallstone and biliary sludge formation during pregnancy.
Bolukbas FF; Bolukbas C; Horoz M; Ince AT; Uzunkoy A; Ozturk A; Aka N; Demirci F; Inci E; Ovunc O
J Gastroenterol Hepatol; 2006 Jul; 21(7):1150-3. PubMed ID: 16824067
[TBL] [Abstract][Full Text] [Related]
8. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.
Friedrich N; Völzke H; Hampe J; Lerch MM; Jørgensen T
Am J Gastroenterol; 2009 Jan; 104(1):89-95. PubMed ID: 19098855
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.
Uhler ML; Marks JW; Voigt BJ; Judd HL
J Clin Endocrinol Metab; 1998 Feb; 83(2):410-4. PubMed ID: 9467549
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.
Simonsen MH; Erichsen R; Frøslev T; Rungby J; Sørensen HT
Drug Saf; 2013 Dec; 36(12):1189-97. PubMed ID: 24174288
[TBL] [Abstract][Full Text] [Related]
11. Effects of leptin on biliary lipids: potential consequences for gallstone formation and therapy in obesity.
Méndez-Sánchez N; Ponciano-Rodrigoez G; Chavez-Tapia N; Uribe M
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):203-8. PubMed ID: 16089354
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy causing gallstone disease.
Khan MK; Jalil MA; Khan SU
Mymensingh Med J; 2008 Jul; 17(2 Suppl):S91-6. PubMed ID: 18946459
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: a case control study.
Sodhi JS; Zargar SA; Khateeb S; Showkat A; Javid G; Laway BA; Parveen S; Khan BA; Yattoo GN; Shah A; Gulzar GM; Khan MA
Indian J Gastroenterol; 2014 Nov; 33(6):507-11. PubMed ID: 25283265
[TBL] [Abstract][Full Text] [Related]
14. Gallstones in New Zealand: composition, risk factors and ethnic differences.
Stringer MD; Fraser S; Gordon KC; Sharples K; Windsor JA
ANZ J Surg; 2013 Jul; 83(7-8):575-80. PubMed ID: 22985390
[TBL] [Abstract][Full Text] [Related]
15. [Pregnancy, oral hormonal contraception and lipid bile composition].
Dökert B; Jaross W; Schentke KU; Trübsbach A; Sarembe B
Dtsch Gesundheitsw; 1978; 33(25):1153-5. PubMed ID: 668501
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of gallstone disease in patients with end-stage renal disease treated with hemodialysis in Korea.
Hahm JS; Lee HL; Park JY; Eun CS; Han DS; Choi HS
Hepatogastroenterology; 2003; 50(54):1792-5. PubMed ID: 14696406
[TBL] [Abstract][Full Text] [Related]
17. Is there a link between oestrogen therapy and gallbladder disease?
Dhiman RK; Chawla YK
Expert Opin Drug Saf; 2006 Jan; 5(1):117-29. PubMed ID: 16370961
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of gallstone disease in a high altitude Saudi population.
Abu-Eshy SA; Mahfouz AA; Badr A; El Gamal MN; Al-Shehri MY; Salati MI; Rabie ME
East Mediterr Health J; 2007; 13(4):794-802. PubMed ID: 17955761
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.
Henriksson P; Einarsson K; Eriksson A; Kelter U; Angelin B
J Clin Invest; 1989 Sep; 84(3):811-6. PubMed ID: 2760214
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.
Chen CH; Huang MH; Yang JC; Nien CK; Etheredge GD; Yang CC; Yeh YH; Wu HS; Chou DA; Yueh SK
J Gastroenterol Hepatol; 2006 Nov; 21(11):1737-43. PubMed ID: 16984599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
